Lilly is studying it in clinical trials for obesity and overweight with weight-related conditions, type 2 diabetes, obstructive sleep apnea, osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
Still have questions about starting weight loss injections with the Aspen Clinic
A $50 million settlement may sound impressive, but if it represented compensation divided among 500 clients, individual recoveries averaged only $100,000 potentially inadequate for cases involving permanent gastroparesis requiring lifetime medical treatment
A.FathiM.PeysokhanM.HashemianA
This analysis only focused on switching patterns and did not look into patients who discontinued their GLP-1 RA in association with this change